These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia. Ando K; Takahashi F; Motojima S; Nakashima K; Kaneko N; Hoshi K; Takahashi K J Clin Oncol; 2013 Feb; 31(6):e69-72. PubMed ID: 23129740 [No Abstract] [Full Text] [Related]
3. Assessment of tocilizumab in the treatment of cancer cachexia. Berti A; Boccalatte F; Sabbadini MG; Dagna L J Clin Oncol; 2013 Aug; 31(23):2970. PubMed ID: 23816970 [No Abstract] [Full Text] [Related]
4. Novel investigational biologics for the treatment of cancer cachexia. Ma JD; Heavey SF; Revta C; Roeland EJ Expert Opin Biol Ther; 2014 Aug; 14(8):1113-20. PubMed ID: 24707881 [TBL] [Abstract][Full Text] [Related]
5. Cachexia in cancer: is it treatable at the molecular level? Vanchieri C J Natl Cancer Inst; 2010 Nov; 102(22):1694-7. PubMed ID: 21060062 [No Abstract] [Full Text] [Related]
7. Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. Garcia JM; Boccia RV; Graham CD; Yan Y; Duus EM; Allen S; Friend J Lancet Oncol; 2015 Jan; 16(1):108-16. PubMed ID: 25524795 [TBL] [Abstract][Full Text] [Related]
8. Losartan: A new treatment for cardiac cachexia? Scherrer-Crosbie M J Mol Cell Cardiol; 2015 Sep; 86():12-3. PubMed ID: 26141529 [No Abstract] [Full Text] [Related]
9. The cancer anorexia-cachexia syndrome. Nelson KA Semin Oncol; 2000 Feb; 27(1):64-8. PubMed ID: 10697022 [TBL] [Abstract][Full Text] [Related]
10. Reply to A. Berti et al. Ando K; Takahashi F; Takahashi K J Clin Oncol; 2013 Aug; 31(23):2971. PubMed ID: 24079020 [No Abstract] [Full Text] [Related]
14. Mitogen-Activated Protein Kinases Inhibitors: Potential Therapeutic Agents for Cancer Cachexia. Baracos VE Mol Cancer Ther; 2017 Feb; 16(2):263-264. PubMed ID: 28159914 [No Abstract] [Full Text] [Related]
15. North Central Cancer Treatment Group (NCCTG). Loprinzi CL J Natl Cancer Inst Monogr; 1996; (20):79-80. PubMed ID: 8750472 [No Abstract] [Full Text] [Related]
16. Thalidomide and cancer cachexia: old problem, new hope? Stroud M Gut; 2005 Apr; 54(4):447-8. PubMed ID: 15753523 [No Abstract] [Full Text] [Related]
17. Clinical evaluation and optimal management of cancer cachexia. Tuca A; Jimenez-Fonseca P; Gascón P Crit Rev Oncol Hematol; 2013 Dec; 88(3):625-36. PubMed ID: 23953794 [TBL] [Abstract][Full Text] [Related]
19. Wasting away: cancer cachexia. Blackburn G Health News; 1998 Mar; 4(4):4. PubMed ID: 9553605 [No Abstract] [Full Text] [Related]
20. [Establishment of new cancer cachexia rat model and evaluation of a promising medicine based on pathophysiology of this model - the mechanism by which rikkunshito ameliorates cancer cachexia]. Terawaki K; Omiya Y; Kase Y Nihon Yakurigaku Zasshi; 2015 Aug; 146(2):81-6. PubMed ID: 26256745 [No Abstract] [Full Text] [Related] [Next] [New Search]